201 related articles for article (PubMed ID: 18181166)
1. CMV antibody prevalence and seroincidence in plateletpheresis donors.
Boeke CE; Pauly ME; Hatch-Stock H; Jackson JB
J Clin Apher; 2008; 23(2):63-5. PubMed ID: 18181166
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
Lazda VA
Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
[TBL] [Abstract][Full Text] [Related]
6. [Blood donor selection in providing anticytomegalovirus-negative blood components].
Koerner K; Freudenberg J; Kubanek B
Dtsch Med Wochenschr; 1989 Feb; 114(6):203-7. PubMed ID: 2537170
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of antibodies against CMV in Grenada].
Rojo MD; García MV; Oyonarte S; Mendoza J; Carazo C; Fernández-Montoya A
Sangre (Barc); 1992 Aug; 37(4):293-5. PubMed ID: 1325073
[TBL] [Abstract][Full Text] [Related]
8. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
11. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
Alao OO; Mamman A; Araoye MO; Joseph E
Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
[TBL] [Abstract][Full Text] [Related]
13. [Significance of cytomegalovirus in blood donation].
Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW
Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951
[TBL] [Abstract][Full Text] [Related]
14. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran.
Tabatabaee M; Tayyebi D
J Matern Fetal Neonatal Med; 2009 Jun; 22(6):517-21. PubMed ID: 19350446
[TBL] [Abstract][Full Text] [Related]
16. Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory.
Fontaine MJ; Jurado C; Miller E; Viele M; Goodnough LT
Transfusion; 2010 Aug; 50(8):1685-9. PubMed ID: 20412530
[TBL] [Abstract][Full Text] [Related]
17. [Satisfaction of paid thrombocyte donors with instrumental thrombocytapheresis].
Puig S; Felder R; Staudenherz A; Kurz M; Kolar I; Höcker P
Infusionsther Transfusionsmed; 1995 Feb; 22(1):14-8. PubMed ID: 7727958
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus seroprevalence and 'cytomegalovirus-safe' seropositive blood donors.
Badami KG; McQuilkan-Bickerstaffe S; Wells JE; Parata M
Epidemiol Infect; 2009 Dec; 137(12):1776-80. PubMed ID: 19480727
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cytomegalovirus in Thai blood donors by monoclonal staining of blood leukocytes.
Amarapal P; Tantivanich S; Balachandra K
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):148-53. PubMed ID: 11485078
[TBL] [Abstract][Full Text] [Related]
20. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
